01 3CinnaGen
02 3LFB Group
03 19Novo Nordisk
04 3Stragen Pharma SA
01 3INJ
02 3Injectable
03 6Injectable Solution
04 3POWDER FOR SOLUTION
05 3Powder and Solvent for Solution for Injection
06 10Solution For Injection
01 7Approved
02 3Authorized
03 3Cancelled
04 3Deregistered
05 3Originator
06 3Schedule D
07 6Blank
01 3AryoSeven (RT)
02 3NIASTASE RT
03 1NovoSeven 1 mg
04 1NovoSeven 2 mg
05 1NovoSeven 5 mg
06 13Novoseven
07 3Sevenfacts
08 3Blank
01 3Canada
02 3Iran
03 3South Africa
04 6Spain
05 10Sweden
06 3Blank
Regulatory Info :
Registration Country : Iran
Coagulation Factor VIIA Recombinant
Brand Name : AryoSeven (RT)
Dosage Form : Injectable
Dosage Strength : 1.2MG
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Coagulation Factor VIIA Recombinant
Brand Name : AryoSeven (RT)
Dosage Form : Injectable
Dosage Strength : 2.4MG
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Coagulation Factor VIIA Recombinant
Brand Name : AryoSeven (RT)
Dosage Form : Injectable
Dosage Strength : 4.8MG
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Sevenfacts
Dosage Form : Solution For Injection
Dosage Strength :
Packaging :
Approval Date : 15/07/2022
Application Number : 20210129000018
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Sevenfacts
Dosage Form : Solution For Injection
Dosage Strength : 2mg
Packaging :
Approval Date : 15/07/2022
Application Number : 20210129000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Sevenfacts
Dosage Form : Solution For Injection
Dosage Strength : 5mg
Packaging :
Approval Date : 15/07/2022
Application Number : 20210129000032
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Novoseven
Dosage Form : Solution For Injection
Dosage Strength :
Packaging :
Approval Date : 25/04/2008
Application Number : 20070710000090
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Novoseven
Dosage Form : Solution For Injection
Dosage Strength : 2mg
Packaging :
Approval Date : 25/04/2008
Application Number : 20070710000106
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Novoseven
Dosage Form : Solution For Injection
Dosage Strength : 5mg
Packaging :
Approval Date : 25/04/2008
Application Number : 20070710000113
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Novoseven
Dosage Form : Solution For Injection
Dosage Strength : 8mg
Packaging :
Approval Date : 28/10/2010
Application Number : 20100715000044
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Novoseven
Dosage Form : Solution For Injection
Dosage Strength : 1.2mg
Packaging :
Approval Date : 23/02/1996
Application Number : 19960223000011
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Novoseven
Dosage Form : Solution For Injection
Dosage Strength : 2.4mg
Packaging :
Approval Date : 23/02/1996
Application Number : 19960223000028
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Novoseven
Dosage Form : Solution For Injection
Dosage Strength : 4.8mg
Packaging :
Approval Date : 23/02/1996
Application Number : 19960223000035
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : NIASTASE RT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date :
Application Number : 2417103
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : NIASTASE RT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 2MG/VIAL
Packaging :
Approval Date :
Application Number : 2417111
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : NIASTASE RT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 5MG/VIAL
Packaging :
Approval Date :
Application Number : 2417138
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Activated recombinant coagulation factor VIIa (rVIIa)
Brand Name : NovoSeven 1 mg
Dosage Form : INJ
Dosage Strength : 1mg/ml
Packaging : 1X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country :
Coagulation Factor VIIA Recombinant
Brand Name :
Dosage Form : Powder and Solvent for Solution for Injection
Dosage Strength : 1.2MG
Packaging : 1 vial of powder + 1 vial of solvent + 1 injection kit
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Regulatory Info :
Registration Country :
Coagulation Factor VIIA Recombinant
Brand Name :
Dosage Form : Powder and Solvent for Solution for Injection
Dosage Strength : 2.4MG
Packaging : 1 vial of powder + 1 vial of solvent + 1 injection kit
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Regulatory Info :
Registration Country :
Coagulation Factor VIIA Recombinant
Brand Name :
Dosage Form : Powder and Solvent for Solution for Injection
Dosage Strength : 4.8MG
Packaging : 1 vial of powder + 1 vial of solvent + 1 injection kit
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
